Back to CVE records
High 8.8HealthcarePublished Sep 6, 2019

CVE-2019-13517In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not re…

Updated under an hour ago ()

Does this affect you?

It affects bd pyxis_enterprise_server and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 1.29%, higher than 70% of scored CVEs.

In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.

CVSS
8.8 HIGH (v3.0, NVD)CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-384
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
1.29% (percentile 70)
Assigned by
icscert
NVD analysis
Modified
Record last updated
Aug 4, 2024
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
bd pyxis_enterprise_server
bd:pyxis_enterprise_server
from 4.4 through 4.12
NVD
bd pyxis_es
bd:pyxis_es
from 1.3.4 through 1.6.1
NVD

References

  • x-refsource-misc, mitigation, third-party-advisory, us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.